Spontaneous nasal perforation in a bevacizumab-treated patient with metastatic breast cancer

被引：4
|
作者：
Rodriguez, Cesar A. [1 ]
Martin, Teresa [1 ]
Lozano, Rebeca [1 ]
Gomez, Amalia [1 ]
Cruz, Juan J. [1 ]
机构：
[1] Hosp Univ Salamanca IBSAL, Dept Med Oncol, Salamanca, Spain
来源：
BREAST JOURNAL | 2017年 / 23卷 / 06期
关键词：
bevacizumab; breast cancer; nasal septum perforation; SEPTUM PERFORATION; PACLITAXEL; THERAPY; TRIAL;
D O I：
10.1111/tbj.12913
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Nasal septum perforation in patients with cancer receiving systemic therapy is rare, and its association with bevacizumab use has described recently in the literature. Here, we report the case of a 34-year-old woman with hormone-sensitive, HER-2/neu negative, metastatic breast cancer who develope a nasal septum perforation during the treatment with paclitaxel and bevacizumab.
引用
收藏
页码：745 / 746
页数：2
相关论文
共 50 条
  • [1] Nasal septum perforation in a bevacizumab-treated patient with metastatic breast cancer
    Traina, Tiffany A.
    Norton, Larry
    Drucker, Karen
    Singh, Buvanesh
    ONCOLOGIST, 2006, 11 (10): : 1070 - 1071
  • [2] Retrobulbar Optic Neuritis in a Bevacizumab-Treated Patient with Metastatic Breast Cancer
    Zhou, Yan
    Zhang, Yi
    Yang, Xinhua
    Fan, Linjun
    Jiang, Jun
    BREAST JOURNAL, 2012, 18 (05): : 502 - 503
  • [3] Nasal septum perforation in a breast cancer patient treated with bevacizumab
    Pinto Marin, A.
    Redondo Sanchez, A.
    Espinosa Arranz, E.
    ANNALS OF ONCOLOGY, 2009, 20 (11) : 1901 - 1902
  • [4] Risk and management of venous thromboembolisms in bevacizumab-treated metastatic colorectal cancer patients
    Yu, Irene
    Chen, Leo
    Ruan, Jenny Y.
    Chang, Jennifer T.
    Cheung, Winson Y.
    SUPPORTIVE CARE IN CANCER, 2016, 24 (03) : 1199 - 1208
  • [5] Risk and management of venous thromboembolisms in bevacizumab-treated metastatic colorectal cancer patients
    Irene Yu
    Leo Chen
    Jenny Y. Ruan
    Jennifer T. Chang
    Winson Y. Cheung
    Supportive Care in Cancer, 2016, 24 : 1199 - 1208
  • [6] Association of VEGF-A Splice Variant mRNA Expression With Outcome in Bevacizumab-Treated Patients With Metastatic Breast Cancer
    Pentheroudakis, George
    Kotoula, Vassiliki
    Kouvatseas, George
    Charalambous, Elpida
    Dionysopoulos, Dimitrios
    Zagouri, Flora
    Koutras, Angelos
    Papazisis, Konstantinos
    Pectasides, Dimitrios
    Samantas, Epaminontas
    Dimopoulos, Meletios A.
    Papandreou, Christos N.
    Fountzilas, George
    CLINICAL BREAST CANCER, 2014, 14 (05) : 330 - 338
  • [7] Nasal septum perforation induced by bevacizumab therapy for metastatic colorectal cancer
    Pina, Paulo
    Teixeira, Monica
    Coimbra, Edite
    Branquinho, Francisco
    BMJ CASE REPORTS, 2024, 17 (12)
  • [8] Correlation of Hypertension and Proteinuria with Outcome in Elderly Bevacizumab-Treated Patients with Metastatic Colorectal Cancer
    Feliu, Jaime
    Salud, Antonieta
    Safont, Maria J.
    Garcia-Giron, Carlos
    Aparicio, Jorge
    Losa, Ferran
    Bosch, Carlos
    Escudero, Pilar
    Casado, Enrique
    Jorge, Monica
    Bohn, Uriel
    Perez-Carrion, Ramon
    Carmona, Alberto
    Custodio, Ana B.
    Maurel, Joan
    PLOS ONE, 2015, 10 (01):
  • [9] A patient presenting nasal septum perforation during bevacizumab-containing chemotherapy for advanced breast cancer
    Fausto Petrelli
    Mary Cabiddu
    Cecilia Barbara
    Sandro Barni
    Breast Cancer, 2011, 18 : 226 - 230
  • [10] A patient presenting nasal septum perforation during bevacizumab-containing chemotherapy for advanced breast cancer
    Petrelli, Fausto
    Cabiddu, Mary
    Barbara, Cecilia
    Barni, Sandro
    BREAST CANCER, 2011, 18 (03) : 226 - 230
12345